Schneeweiss / Schettler | Cardiovascular Drug Therapy in the Elderly | Buch | 978-0-89838-883-1 | sack.de

Buch, Englisch, Band 72, 386 Seiten, Format (B × H): 156 mm x 234 mm, Gewicht: 1620 g

Reihe: Developments in Cardiovascular Medicine

Schneeweiss / Schettler

Cardiovascular Drug Therapy in the Elderly

Buch, Englisch, Band 72, 386 Seiten, Format (B × H): 156 mm x 234 mm, Gewicht: 1620 g

Reihe: Developments in Cardiovascular Medicine

ISBN: 978-0-89838-883-1
Verlag: Springer Us


Cardiovascular drug therapy has markedly progressed in the recent decades. Not only have new drugs been introduced to clinical practice, but new classes of drugs have been developed. While in 1960 the practicing cardiolo­ gist had a selection of about only ten drugs, in 1987 about 150 drugs are routinely used in cardiovascular diseases. Elderly patients, however, usually do not enjoy the full benefit of this progress. This might be due to lack of knowledge, a conservative approach, or the worldwide tendency not to try new drugs in the elderly. It is now clear that the majority of patients that will be treated in car­ diovascular clinics will be, in the near future, elderly patients. Even now, elderly patients form about one-third of the patients with cardiovascular diseases. These patients are approached, however, according to criteria devel­ oped for younger populations. This is despite the fact that elderly patients differ from younger ones in most aspects, including pathology, epidemiol­ ogy, pathophysiology, diagnostic approach, management, pharmacology, pharmacokinetics, rehabilitation, and supportive treatment. It is the purpose of this book to present to the clinician all drugs with which there is clinical experience in the elderly or which might be potentially useful for the elderly with cardiovascular diseases. The data are presented without the authors taking a position. This should allow the clinicians to make their own selection and individualize treatment, vii viii Preface based on a wide data base. Comparative data are presented only when specific comparative studies were performed.
Schneeweiss / Schettler Cardiovascular Drug Therapy in the Elderly jetzt bestellen!

Zielgruppe


Research

Weitere Infos & Material


I. Agents Directly Enhancing Myocardial Contractility.- 1. Introduction.- 2. Digitalis glycosides.- 3. Bipyridine derivatives.- 4. Dobutamine.- 5. Dopamine.- 6. MDL-17,043 (Piroximone).- 7. Ibopamine.- II. Vasodilators.- 8. Introduction.- 9. Captopril.- 10. Enalapril.- 11. Enalaprilat.- 12. Nifedipine.- 13. Nitrendipine.- 14. Verapamil.- 15. Diltiazem.- 16. Prazosin.- 17. Urapidil.- 18. Nitrates.- 19. Nitroprusside.- 20. Hydralazine.- 21. Endralazine.- 22. Minoxidil.- III. Antiarrhythmic Drugs.- 23. Introduction.- 24. Quinidine.- 25. Disopyramide.- 26. Lidocaine.- 27. Tocainide.- 28. Lorcainide.- 29. Propafenone.- 30. Mexiletine.- 31. Ethmozine.- 32. Encainide.- 33. Amiodarone.- 34. Adenosine.- IV. Beta-Adrenoreceptor Blockers.- 35. Introduction.- 36. Propranolol.- 37. Atenolol.- 38. Metoprolol.- 39. Oxprenolol.- 40. Alprenolol.- 41. Sotalol.- 42. Esmolol.- V. Centrally Acting Antihypertensive Agents.- 43. Introduction.- 44. Methyldopa.


Ihre Fragen, Wünsche oder Anmerkungen
Vorname*
Nachname*
Ihre E-Mail-Adresse*
Kundennr.
Ihre Nachricht*
Lediglich mit * gekennzeichnete Felder sind Pflichtfelder.
Wenn Sie die im Kontaktformular eingegebenen Daten durch Klick auf den nachfolgenden Button übersenden, erklären Sie sich damit einverstanden, dass wir Ihr Angaben für die Beantwortung Ihrer Anfrage verwenden. Selbstverständlich werden Ihre Daten vertraulich behandelt und nicht an Dritte weitergegeben. Sie können der Verwendung Ihrer Daten jederzeit widersprechen. Das Datenhandling bei Sack Fachmedien erklären wir Ihnen in unserer Datenschutzerklärung.